script.reportAU
Sponsor

Emerge Health

11 PBAC submissions on file, active 2014–2020. 82% have been recommended.

Submissions
11
2014 → 2020
Win rate
82 %
9 recommended of 11 bucketable
Drugs
8 · 6 listed
unique molecules submitted
PBS spend captured
FY-latest govt benefit on owned drugs

Drug portfolio

Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.

Therapy area mix

Gastroenterology 3
Neurology 3
Metabolic 2
Hepatology 2
Respiratory 1

Activity by year

2014 (1) · 2015 (1) · 2017 (1) · 2018 (2) · 2019 (2) · 2020 (4)

Open on full dashboard →